ArticleAlimentary pharmacology & therapeutics2023
Letter: Experience of switching vedolizumab treatment from intravenous to subcutaneous formulation in Hungary.
Péter Bacsur et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it